Good news about TB? New trial holds promise
WASHINGTON — The news around tuberculosis in the world generally is awful. There are an estimated 1.4 million deaths and […]
WASHINGTON — The news around tuberculosis in the world generally is awful. There are an estimated 1.4 million deaths and […]
WASHINGTON — At an event heralding the launch of a new clinical trial that tests tuberculosis drugs in combination, a
Goal is to find new treatment that takes months, not years, and cures multiple forms of tuberculosis Announcement made at
PRESS RELEASE TB Alliance Launches Combination Drug Trial, Establishes New Pathway to TB and MDR-TB Treatment VIDEO Christine Lubinski Introduction
The TB Alliance and other organizations spearheading the research and development of new and improved tools to treat, diagnose, and
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a grant to the TB Alliance as a member
TB Alliance announces the appointment of David Greeley as Senior Vice President, External Affairs. Mr. Greeley will be responsible for
Dr. Tim McHugh Director University College London (UCL) Centre for Clinical Microbiology – REMox TB UCL Lead The microbiology laboratory
Dr Jane Rahedi Ong’ang’o Community Engagement Coordinator Kenya Medical Research Institute (KEMRI), Nairobi, Kenya In January 2010, the Phase III
Dr Stephen H. Gillespie MD DSc Sir James Black Professor of Medicine University of St Andrews University Chief Investigator For